We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Digital Quality Control Tool Identifies Cells in Blood

By LabMedica International staff writers
Posted on 21 May 2013
An External Quality Assurance (EQA) program in hematology is web-based and located on a cloud server. It can be run from any computer without the need for software installation.

The program is online, which means that the quality organization can more easily collect and create a customized database of interesting patient cases. The program uses digital images of white and red cells in blood and other body fluids.

CellaVision (Lund, Sweden) has signed an agreement with Equalis (Uppsala, Sweden), a provider of external quality assessment for clinical laboratory tests. Equalis is investing in CellaVision's new proficiency testing program for the identification of cells in blood and other body fluids, CellaVision Proficiency Software. The order comprises a license for 350 users. During the year, the product will be introduced into Equalis' quality assurance scheme for Swedish clinical laboratories in Hematology.

When compared to the traditional testing methods which use blood smears on glass slides, this software is efficient, user friendly, and allows all participants to view and identify the same cells. This simplifies administration, performance, and monitoring of the test, as well as creating conditions for faster analysis and more accurate reporting.

"With CellaVision Proficiency Software, we reach out easily to our scheme participants in hematology and can offer them a digital quality control tool that creates conditions for increased knowledge and more standardized test results," said Gunnar Nordin, managing director and CMO at Equalis. "One of the great benefits of the program, in addition to allowing us to easily distribute, monitor, and follow up tests on-line, is that participants get instant feedback on their performance in form of valuable statistics. The program is both a testing tool and a source to increase knowledge."

CellaVision Proficiency Software is sold as an annual license directly by CellaVision. The program is available in two versions, the Enterprise Edition for external quality assessment organizations with up to 2000 users, and the Professional Edition for laboratories and universities with 10–100 users. The Professional Edition includes a customized web portal. More information can be found online (Please see Related Links below).

Equalis is a not-for-profit organization that provides external quality assessment of clinical laboratory investigations. It is accredited by Swedac as a provider of interlaboratory comparisons in laboratory medicine. Now Equalis will incorporate the CellaVision Proficiency Software in its quality assessment program for hematology analyses.

CellaVision is a medical technology company that develops and sells its own systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals.

Related Links:

CellaVision
CellaVison Proficiency Software
Equalis



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.